Doctor profile · Federal record
Dr. Dwidgelyne Remogene, ARNP, FNP-BC
Family Nurse Practitioner · Tampa, FL
- NPI 1114590106
- MIPS 77.4 / 100 · 2023
- 5 yrs on file
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
611 S Howard Ave
Tampa, FL 336062412
(813) 259-9911
Credentials & registration
- NPI registered
- July 2021 — 5 yrs on file
- Profile last updated
- August 17, 2021
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Florida #11012921
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1114590106. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,891
Distinct HCPCS
3
Medicare allowed
$71,108
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2356 |
Injection, tezepelumab-ekko, 1 mg | 3,360 | 11 | $18 | |
99211 |
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 488 | 457 | $19 | |
96372 |
Injection of drug or substance under skin or into muscle | 43 | 33 | $12 |
In context: peer comparison
Among 125 peers in this city , average services per provider: 311. This provider delivers 13× the peer median.Open Payments
Industry payments received
All-time total
$133
Transactions
1
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | 1 | $133.35 |
By nature of payment
Frequently asked questions
What is Dr. Dwidgelyne Remogene's medical specialty?
Dr. Dwidgelyne Remogene practices Family Nurse Practitioner in Tampa, FL.
Where does Dr. Dwidgelyne Remogene practice?
Dr. Dwidgelyne Remogene practices at 611 S Howard Ave, Tampa, FL 336062412. Office phone: 8132599911.
What is Dr. Dwidgelyne Remogene's NPI?
Dr. Dwidgelyne Remogene's National Provider Identifier (NPI) is 1114590106, issued by NPPES.
What procedures does Dr. Dwidgelyne Remogene commonly perform?
Top Medicare-reported procedures in 2023: Injection, tezepelumab-ekko, 1 mg (HCPCS J2356); Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS 99211); Injection of drug or substance under skin or into muscle (HCPCS 96372). Source: CMS Medicare Physician & Other Practitioners file.